This meta-analysis aimed to include the latest studies and update the concept regarding whether the PlA1/A2 gene polymorphism predicts laboratory aspirin resistance and/or cardiovascular outcomes, and whether laboratory detected aspirin resistance predicts cardiovascular outcomes in CAD patients who are on aspirin treatment. Here, POU2F3 is linked to coronary artery disorder.